BLCO

Bausch + Lomb Corporation

• Seeking Alpha·2d ago

  Bausch + Lomb: The Market Is Pricing The Balance Sheet, Not The Eye-Care Engine

• Simply Wall St·3d ago

  Did Bausch + Lomb’s (BLCO) Board Overhaul Amid Weak Returns Just Shift Its Investment Narrative?

• Benzinga·5d ago

  Carl Icahn Trims JetBlue, AEP Stakes While Sitting Out New Stock Bets

• Simply Wall St·08/13 22:22

  Bausch + Lomb (BLCO) Could Be 57% Undervalued As Board Refresh Draws Attention

• The Motley Fool·08/13 13:00

  Insider Sheds Nearly 53,000 Shares of Consumer Health Stock, Valued at Almost $900,000

• TipRanks·08/13 10:56

  Citi Sticks to Its Buy Rating for Bausch + Lomb Corporation (BLCO)

• Simply Wall St·08/12 18:29

  Is Bausch + Lomb’s Raised 2026 Outlook And Board Refresh Altering The Investment Case For BLCO?

• Seeking Alpha·08/11 13:40

  These stocks have some of Wall Street’s lowest short interest

• Seeking Alpha·08/06 17:24

  Bausch + Lomb reports Q2 results

• TipRanks·08/06 11:25

  Bausch + Lomb reaffirms FY26 revenue $5.44B-$5.54B, consensus $5.49B

• Simply Wall St·08/03 19:15

  Did Bausch + Lomb’s Stronger Q2 and Higher 2026 Revenue Guidance Just Shift BLCO’s Investment Narrative?

• Seeking Alpha·08/03 13:35

  Most and least shorted mid- to mega-cap healthcare stocks at the end of July

• Benzinga·08/03 10:37

  HC Wainwright & Co. Maintains Buy on Bausch & Lomb, Raises Price Target to $21

• TipRanks·08/03 10:10

  Bausch + Lomb price target raised to $21 from $20 at H.C. Wainwright

• TipRanks·08/01 00:22

  Bausch + Lomb Earnings Call Signals Growing Momentum